Reslin



Indications and Reactions:

Role Indications Reactions
Primary
Depression 26.7%
Insomnia 20.0%
Panic Disorder 13.3%
Anxiety 8.3%
Anorexia 6.7%
Parkinsonism 5.0%
Adjustment Disorder 3.3%
Alcoholic Psychosis 3.3%
Obsessive-compulsive Disorder 3.3%
Alcoholism 1.7%
Anxiety Disorder 1.7%
Constipation 1.7%
Hypertriglyceridaemia 1.7%
Orthostatic Hypotension 1.7%
Schizophrenia 1.7%
Suicide Attempt 19.0%
Neuroleptic Malignant Syndrome 9.5%
Renal Failure Acute 9.5%
Respiratory Disorder Neonatal 9.5%
Drug Interaction 4.8%
Pancytopenia 4.8%
Pulmonary Thrombosis 4.8%
Rhabdomyolysis 4.8%
Self Injurious Behaviour 4.8%
Septic Shock 4.8%
Serotonin Syndrome 4.8%
Supraventricular Tachycardia 4.8%
Systemic Lupus Erythematosus 4.8%
Thirst 4.8%
White Blood Cell Count Decreased 4.8%
Secondary
Depression 22.5%
Anxiety 20.6%
Insomnia 19.0%
Drug Use For Unknown Indication 13.0%
Anorexia 3.2%
Anaesthesia Procedure 2.8%
Adjustment Disorder 2.4%
Behavioural And Psychiatric Symptoms Of Dementia 2.4%
Pain 2.4%
Bipolar Disorder 1.6%
Dysthymic Disorder 1.6%
Postpartum Depression 1.6%
Sleep Disorder 1.6%
Androgenetic Alopecia 0.8%
Angina Pectoris 0.8%
Blood Pressure Increased 0.8%
Cerebral Infarction 0.8%
Dementia 0.8%
Dementia Alzheimer's Type 0.8%
Eating Disorder 0.8%
Delirium 12.2%
Parkinsonism 12.2%
Urinary Incontinence 10.2%
Respiratory Disorder Neonatal 8.2%
Septic Shock 6.1%
Tremor 6.1%
Altered State Of Consciousness 4.1%
Feeling Cold 4.1%
Hepatic Function Abnormal 4.1%
Platelet Count Decreased 4.1%
Sleep Apnoea Syndrome 4.1%
Somnolence 4.1%
Stupor 4.1%
Therapeutic Agent Toxicity 4.1%
Death 2.0%
Drug Eruption 2.0%
Gastrointestinal Haemorrhage 2.0%
Hyperglycaemia 2.0%
Intentional Overdose 2.0%
Overdose 2.0%
Concomitant
Insomnia 16.9%
Depression 15.6%
Pain 7.2%
Product Used For Unknown Indication 6.0%
Parkinson's Disease 5.4%
Drug Use For Unknown Indication 5.3%
Metastatic Renal Cell Carcinoma 5.3%
Hypertension 4.6%
Psychiatric Symptom 4.1%
Dementia Alzheimer's Type 3.7%
Bipolar Disorder 3.3%
Asthma 3.2%
Rheumatoid Arthritis 2.8%
Prophylaxis 2.6%
Extradural Abscess 2.5%
Hepatic Cirrhosis 2.5%
Orthostatic Hypotension 2.5%
Constipation 2.1%
Pyrexia 2.1%
Spondylitis 2.1%
Loss Of Consciousness 10.1%
Restlessness 9.2%
Pyrexia 8.4%
White Blood Cell Count Decreased 7.6%
Hepatic Function Abnormal 6.7%
Suicide Attempt 5.9%
Rhabdomyolysis 5.0%
Somnolence 5.0%
Syncope 5.0%
Depressed Level Of Consciousness 4.2%
Weight Increased 4.2%
Death 3.4%
Drug Eruption 3.4%
Irritability 3.4%
Melaena 3.4%
Renal Impairment 3.4%
Respiratory Depression 3.4%
Stress 3.4%
Aspartate Aminotransferase Increased 2.5%
Completed Suicide 2.5%
Interacting
Cataplexy 46.7%
Narcolepsy 40.0%
Depression 6.7%
Dysmenorrhoea 6.7%
Drug Interaction 100.0%